BioSpace News Archive

Genetown

Alnylam Announces 2020 Product and Pipeline Goals and Provides Updates at R&D Day

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, is hosting an R&D Day in New York City today

November 22, 2019
·
13 min read
Biotech Bay

Tivic Health’s ClearUP Sinus Pain Relief Named To TIME’S List Of The 100 Best Inventions Of 2019

ClearUP® Sinus Pain Relief from Tivic Health™ Systems Inc. was named today to TIME’s 2019 Best Inventions in the healthcare category.

November 22, 2019
·
3 min read
Biotech Bay

Medable Discusses Future of Digital Trials on Health Technology Research Panel at the American Heart Association’s Health Tech & Innovation Summit 2019

Medable Inc., a leading provider of a digital trials platform that connects patients, sites and clinical trial teams, today announced its participation at the American Heart Association (AHA) Health Tech & Innovation Summit on November 16-18, in Philadelphia, Pennsylvania.

November 22, 2019
·
2 min read
Business

Horizon Therapeutics plc Opens New Manufacturing and R&D Facility in South San Francisco

Horizon Therapeutics plc (Nasdaq: HZNP) announced today the opening of its new office in South San Francisco, located at 2 Tower Place, 12th floor

November 22, 2019
·
3 min read
Business

ValueHealth Announces Elizabeth Jaekle as Mid-Atlantic Regional President

ValueHealth, LLC a privately held, nationally trusted digital and surgical healthcare partner, is pleased to announce the hiring of Elizabeth Jaekle as Mid-Atlantic Regional President

November 22, 2019
·
5 min read
Business

Meritech Appoints Paul Barnhill as Chief Technology Officer, Troy Hale as VP Of Operations

Meritech today announced the appointment of Paul Barnhill as Chief Technology Officer and Troy Hale as Vice President of Operations

November 22, 2019
·
3 min read
Biotech Bay

Agilent Companion Diagnostic Expands CE-IVD mark in Europe to include Head and Neck Squamous Cell Carcinoma (HNSCC)

Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labeled for use in HNSCC in the European Union.

November 22, 2019
·
4 min read
Genetown

SOLIRIS® (eculizumab) Receives Approval in Japan for the Prevention of Relapse in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the extension of the current marketing authorization of SOLIRIS® (eculizumab) to include the prevention of relapse in patients with anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD), including neuromyelitis optica.

November 22, 2019
·
18 min read
Business

Points of Light Honors St. Jude Children’s Research Hospital Volunteer With Daily Point of Light on 30th Anniversary of Award

Memphis volunteer Jason Farmer recognized for outstanding commitment to community; organization revisits historic roots to celebrate milestone.

November 22, 2019
·
5 min read
Deals

Phenomics Health Inc. Acquires Patented Pharmacometabolomic Technology

Phenomics Health Inc., a bioinformatics platform-based precision medicine company, today announced it has acquired the patented pharmacometabolomic technology portfolio of Precera Bioscience, based in Franklin, Tenn.

November 22, 2019
·
5 min read